跳至主要内容
临床试验/ITMCTR2200006024
ITMCTR2200006024尚未招募1 期

Clinical evaluation of Kang's Ling-He Granules in the treatment of obese metabolic-related fatty liver disease

Xiamen Hospital of TCM0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 60(—)
性别
All

入选标准

  • Referring to diagnostic criteria for MAFLD based on the new definition of metabolic fatty liver disease in 2020, the diagnostic criteria of Phlegm, Dampness and Blood Stasis Syndrome established by the consensus opinion on the diagnosis and treatment of non-alcoholic fatty liver disease by integrated traditional Chinese and western medicine (2017) are as follows::?Age 18-60 years; ?Compliance with MAFLD (obesity type) diagnostic criteria and TCM phlegm, dampness, blood stasis syndrome diagnostic criteria; ?24=BMI<30kg/m2; ?MRI PDFF > 8 %, willing to accept regular physical and chemical examinations; ?Sign informed consent.

排除标准

  • ?Alanine aminotransferase / aspartate aminotransferase > 5 × ULN ( standard upper limit ), total bilirubin > 2 × ULN; ?Alcoholic fatty liver disease; ?Combined with viral, autoimmune and other liver diseases, or taking drugs that may cause fatty liver; ?Combined with diabetes, malignant tumors, connective tissue diseases and severe heart, liver, hematopoietic, and nervous system complications , Or clearly have other important diseases; ?TCM Syndrome Differentiation of Liver and Kidney Yin Deficiency, Spleen and Kidney Yang Deficiency and Other Typical Deficiency Syndrome; ?Pregnant or breastfeeding women, allergic physique, allergic to drugs, and patients with mental illness; ?Patients who have undergone gastrointestinal bariatric surgery within the past year or who have taken weight-loss drugs within the past three months have lost >10%; ?Patients who took other therapeutic drugs in the past three months affected efficacy evaluation or participated in other clinical trials in the past month.

研究者

发起方
Xiamen Hospital of TCM

相似试验